Guobang Pharma Ltd. (SHA:605507)
China
· Delayed Price · Currency is CNY 24.22
+0.36 (1.51%)
Apr 29, 2026, 3:00 PM CST
Guobang Pharma Revenue
Guobang Pharma had revenue of 1.52B CNY in the quarter ending March 31, 2026, with 5.61% growth. This brings the company's revenue in the last twelve months to 6.09B, up 1.67% year-over-year. In the year 2025, Guobang Pharma had annual revenue of 6.01B with 2.05% growth.
Revenue (ttm)
6.09B
Revenue Growth
+1.67%
P/S Ratio
2.19
Revenue / Employee
1.43M
Employees
4,251
Market Cap
13.33B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zhejiang Hisun Pharmaceutical | 10.31B |
| Shenzhen Chipscreen Biosciences | 910.06M |
| Tibet Rhodiola Pharmaceutical Holding Co. | 2.98B |
| Zhejiang Medicine | 8.82B |
| Shanghai Shyndec Pharmaceutical | 9.36B |
| Beijing Aosaikang Pharmaceutical | 1.83B |
| Ningbo Menovo Pharmaceutical | 1.56B |
| Shenzhen Hepalink Pharmaceutical Group | 5.48B |